FDA approves silicone breast implants in US

Silicone gel breast implants have been approved for use in breast reconstruction and augmentation  procedures by the US Food and Drug Administration (FDA), following a 14-year ban.

The FDA has approved applications by two manufacturers, Mentor and Allergan, although the implants are only to be used for cosmetic purposes in women over the age of 22.

The decision has been applauded by both the American Society for Aesthetic Plastic Surgery (Asaps) and the American Society of Plastic Surgeons (Asps), which said the move would allow American women to make "informed choices about their health care".

Dr James Stuzin, president of Asaps, commented: "It is clear that the agency has carefully evaluated the data presented by the manufacturers, as well as the testimony of physicians, patients and advocacy groups and has made a thoughtful decision to give our patients the access to silicone gel breast implants that women in 60 countries around the world have."

The FDA banned the use of silicone gel breast implants in the early 1990s, following concerns that leaking implants were making women ill and suggestions of a link with cancer and lupus.

However, studies have failed to verify any such links and Dr Daniel Schultz, head of medical devices at the FDA, said that there was reasonable assurance that the implants were safe and effective.

Silicone implants are said to look and feel more natural than those filled with saline, which frequently suffer from visible rippling and deflation.

Comment on this page »


Latest news

Chelsea and Westminster named the best place to work in the NHS for 2015

Nuffield Health opens doors of new Cambridge Hospital

Nuffield Health plans to open state-of-the-art diagnostic suite

FDA approves silicone breast implants in US
Connect with us on:

This site compiles with the HONcode standard for trustworthy health information